ANDAs For Drug/Device Combos Face High Bar At US FDA; Epipen, Advair May Benefit
Executive Summary
Generics must be able to be administered without provider intervention or patient retraining, draft guidance says.
You may also be interested in...
Generic Advair's Labeling Variation Stems From Permissible Design Differences, US FDA Says
Patient instructions for use of Mylan’s fluticasone/salmeterol generic are noticeably different from GSK’s reference listed drug but fall within the ‘different manufacturers’ exception to the ‘same labeling’ requirement.
Gottlieb's Complex Generics Remarks Could Signal (Some) Increased Flexibility
US FDA commissioner spoke to agency scientists and researchers at Generic Drug Science Day, where he discussed future plans to facilitate complex generic development.
Gottlieb's Complex Generics Remarks Could Signal (Some) Increased Flexibility
US FDA commissioner spoke to agency scientists and researchers at Generic Drug Science Day, where he discussed future plans to facilitate complex generic development.